1. Home
  2. SCPH vs OPFI Comparison

SCPH vs OPFI Comparison

Compare SCPH & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • OPFI
  • Stock Information
  • Founded
  • SCPH 2013
  • OPFI 2009
  • Country
  • SCPH United States
  • OPFI United States
  • Employees
  • SCPH N/A
  • OPFI N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • OPFI Finance: Consumer Services
  • Sector
  • SCPH Health Care
  • OPFI Finance
  • Exchange
  • SCPH Nasdaq
  • OPFI Nasdaq
  • Market Cap
  • SCPH 299.0M
  • OPFI 343.1M
  • IPO Year
  • SCPH 2017
  • OPFI N/A
  • Fundamental
  • Price
  • SCPH $5.67
  • OPFI $10.13
  • Analyst Decision
  • SCPH Buy
  • OPFI Buy
  • Analyst Count
  • SCPH 3
  • OPFI 2
  • Target Price
  • SCPH $12.00
  • OPFI $11.75
  • AVG Volume (30 Days)
  • SCPH 2.0M
  • OPFI 965.4K
  • Earning Date
  • SCPH 11-12-2025
  • OPFI 10-29-2025
  • Dividend Yield
  • SCPH N/A
  • OPFI 9.88%
  • EPS Growth
  • SCPH N/A
  • OPFI N/A
  • EPS
  • SCPH N/A
  • OPFI N/A
  • Revenue
  • SCPH $49,969,000.00
  • OPFI $320,831,000.00
  • Revenue This Year
  • SCPH $104.30
  • OPFI $118.17
  • Revenue Next Year
  • SCPH $76.06
  • OPFI $11.29
  • P/E Ratio
  • SCPH N/A
  • OPFI N/A
  • Revenue Growth
  • SCPH 107.79
  • OPFI 31.26
  • 52 Week Low
  • SCPH $1.94
  • OPFI $4.41
  • 52 Week High
  • SCPH $6.28
  • OPFI $17.73
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.40
  • OPFI 38.42
  • Support Level
  • SCPH $5.64
  • OPFI $10.55
  • Resistance Level
  • SCPH $5.65
  • OPFI $12.45
  • Average True Range (ATR)
  • SCPH 0.03
  • OPFI 0.59
  • MACD
  • SCPH -0.02
  • OPFI -0.16
  • Stochastic Oscillator
  • SCPH 66.67
  • OPFI 4.58

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About OPFI OppFi Inc.

OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.

Share on Social Networks: